News
TINLF
9.78
NaN%
--
Nomura Sticks to Its Hold Rating for Teijin (TINLF)
TipRanks · 4d ago
Teijin (TINLF) Gets a Hold from SBI Securities
TipRanks · 08/14 10:06
Teijin Lifts Q1 Earnings, Affirms FY2026 Guidance Amid Portfolio Shift
TipRanks · 08/04 02:52
Teijin Swings to Strong Profit and Lifts FY2026 Outlook Despite Revenue Decline
TipRanks · 08/04 02:52
Teijin Finalizes Merger Deal to Create Joint Venture With Asahi Kasei
TipRanks · 07/30 07:37
SMBC Nikko Sticks to Its Hold Rating for Teijin (TINLF)
TipRanks · 07/09 10:36
Morgan Stanley Reaffirms Their Sell Rating on Teijin (TINLF)
TipRanks · 07/09 10:06
Teijin Corrects Details of Treasury Share Disposal for Executive Stock Incentive Plans
TipRanks · 06/30 08:23
Teijin Books ¥10.7 Billion Dividend From Subsidiary in Q1 FY2026
TipRanks · 06/26 07:25
Mizuho Securities Reaffirms Their Hold Rating on Teijin (TINLF)
TipRanks · 06/25 10:46
Teijin to Dispose of Treasury Shares for Expanded Global Executive Stock Compensation
TipRanks · 06/19 07:52
Nomura Reaffirms Their Hold Rating on Teijin (TINLF)
TipRanks · 05/28 10:08
SBI Securities Sticks to Its Hold Rating for Teijin (TINLF)
TipRanks · 05/27 11:00
Teijin Sees Profit Dip in FY2025, Targets Recovery and Stable Dividend in FY2026
TipRanks · 05/11 02:54
Teijin Swings to Deep Loss as Revenue Falls and Balance Sheet Shrinks in FY2025
TipRanks · 05/11 02:53
Teijin (TINLF) Receives a Hold from SMBC Nikko
TipRanks · 04/08 10:19
SBI Securities Remains a Hold on Teijin (TINLF)
TipRanks · 03/31 10:45
Teijin Slashes FY2026 Profit Outlook on Pharma Impairment and Tax Asset Write-Down
TipRanks · 03/31 09:49
Teijin to Book ¥12.9 Billion Dividend Income From Chinese Subsidiary
TipRanks · 03/17 06:58
Morgan Stanley Remains a Sell on Teijin (TINLF)
TipRanks · 03/09 10:36
More
Webull provides a variety of real-time TINLF stock news. You can receive the latest news about Teijin through multiple platforms. This information may help you make smarter investment decisions.
About TINLF
Teijin Ltd is a Japan-based company mainly engaged in the materials, textiles and products, healthcare, information technology (IT) and other business. It has four business segments. The Material segment includes the high performance materials business, which manufactures and sells aramid fibers, resins and others, and the composite molding materials business, which manufactures and sells composite molding materials. The Textiles and Products segment manufactures and sells textile products and manufactures and sells polyester fibers and textiles. The Healthcare segment manufactures and sells pharmaceuticals and medical devices, provides home medical services, and manufactures and sells other healthcare-related products. IT segment operates, develops, and maintains information systems, and provides electronic comic distribution services. It also manufactures and sells battery components, and develops, manufactures and sells regenerative medicine products and implantable medical devices.